| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |